entertainment -WSS

entertainment

author：entertainment 2025-09-28 00:51:15 - browse：39

JOSEPH PREZIOSO/AFP via Getty Images

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that the drug was both safe and offered modest pain relief. But the findings also prompted fresh debate on Tuesday about how widely used the therapy would be should it win regulatory approval.

The company reported that its small molecule drug, VX-548, outperformed placebo in a pair of pain relief trials that recruited patients who had gotten an abdominoplasty (tummy tuck) or bunion surgery. The study also found that the drug was generally safe, with fewer patients on the medication reporting adverse events than those who had taken a placebo. But there was a catch: VX-548 didn’t outperform a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint. And in the bunionectomy study, the opioid comparator beat VX-548 on pain relief.

“While this study was not explicitly designed to test VX-548 vs. the opioid comparator, this may complicate the prescribing decision in the acute setting, where patients often take a short course of treatment and efficacy is a primary consideration,” Stifel market analyst Paul Matteis wrote in a note to investors, adding that results from three Phase 3 studies were positive overall.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Startup Neumora takes a novel depression drug to Phase 3

hotspot

WSS

Guardant Health colon cancer test endorsed by FDA advisory panel

How Medicaid coverage policies for immigrants impact new moms

In early work, researchers turn to CRISPR to treat Alzheimer's

Louisiana bill approved classifying abortion pills as controlled substances

Louisiana bill approved classifying abortion pills as controlled substances

New research sheds light on how often breast cancer is overdiagnosed

entertainment

entertainment

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Group opposing PBM reform sets lobbying record

How to save PrEP access — and even expand it

Protect nursing home residents from future pandemics

As demand for Covid shots wanes, Moderna seeks its next success

Decentralized clinical trials need collaboration to achieve wider use

Malaria cases in Florida and Texas: Here’s what you need to know

In early work, researchers turn to CRISPR to treat Alzheimer's

Malaria cases in Florida and Texas: Here’s what you need to know

Decentralized clinical trials need collaboration to achieve wider use

hotspot

How Medicaid coverage policies for immigrants impact new moms

Google and Epic fight stronger regulation of AI in health care

How Medicaid coverage policies for immigrants impact new moms

Unmasking the 'centricity' illusion in clinical trials

Medical students need to learn the potent medicine of empathy

Unmasking the 'centricity' illusion in clinical trials

focus

Wikipedia

hotspot

hotspot